From Mexican health authority, COFEPRIS
Biocon announced that its Insulin Glargine has been approved by COFEPRIS, the Mexican health authority, through its partner PiSA Farmaceutica (PiSA).Powered by Capital Market - Live News
Biocon gets approval for Insulin Glargine
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Apr 09 2015 | 9:57 PM IST
